Literature DB >> 11809130

[Quality of life in asthma: reliability and validity of the short form generic questionnaire (SF-36) applied to the population of asthmatics in a public health area].

M J Espinosa De Los Monteros1, J Alonso, J Ancochea, A González.   

Abstract

OBJECTIVE: To analyze the reliability and validity of the short form of the generic quality of life scale (SF-36) when used with our asthmatic patients.
METHODS: Two hundred nineteen adults with asthma of any etiology and without limits on sex, type or severity of asthma who were being treated at 10 health clinics (Madrid, Area 2) filled in the questionnaire. Reliability was calculated by an analysis of internal consistency and validity by studying the correlation among certain variables (patient age, age of onset, PEF, FEV1 and severity according to consensus criteria) and the analysis of differences on each of the dimensions encompassing such variables.
RESULTS: The highest score (best quality of life) was observed in the dimension of role limitations due to emotional problems (80 37) and the lowest was seen for perception of general health (50.4 24). The percentage of patients with the lowest scores ranged from 0 to 5.8% and the percentage with the highest scores ranged from 0.4 to 19.8%. The Cronbach alpha coefficient was greater than 0.7 (range 0.77-0.80). Mean scores related to level of severity were significantly better for men than for women on only three dimensions and for mild and moderate severity groups. All dimensions except role limitations due to emotional and physical problems were significantly related to FEV1%.
CONCLUSION: The reliability and validity of the Spanish version of the SF-36 questionnaire is satisfactory when applied to asthmatic patients, making it an appropriate way to assess quality of life.

Entities:  

Mesh:

Year:  2002        PMID: 11809130     DOI: 10.1016/s0300-2896(02)75139-9

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  4 in total

1.  The impact of asthma and aspirin sensitivity on quality of life of patients with nasal polyposis.

Authors:  Isam Alobid; Pedro Benítez; Manuel Bernal-Sprekelsen; José María Guilemany; Cesar Picado; Joaquim Mullol
Journal:  Qual Life Res       Date:  2005-04       Impact factor: 4.147

2.  Validation of the spanish version of the Multiple Sclerosis International Quality of Life (Musiqol) questionnaire.

Authors:  Oscar Fernández; Victoria Fernández; Karine Baumstarck-Barrau; Luis Muñoz; Maria del Mar Gonzalez Alvarez; José Carlos Arrabal; Antonio León; Ana Alonso; Jose Carlos López-Madrona; Rafael Bustamante; Gloria Luque; Miguel Guerrero; Elisabetta Verdun di Cantogno; Pascal Auquier
Journal:  BMC Neurol       Date:  2011-10-18       Impact factor: 2.474

3.  Psychometric study of the SF-36v2 in hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).

Authors:  Paola Palao-Ocharan; Nieves Prior; Elia Pérez-Fernández; Magdalena Caminoa; Teresa Caballero
Journal:  Orphanet J Rare Dis       Date:  2022-03-02       Impact factor: 4.123

4.  Nasal Polyposis Quality of Life (NPQ): Development and Validation of the First Specific Quality of Life Questionnaire for Chronic Rhinosinusitis with Nasal Polyps.

Authors:  Ilaria Baiardini; Giovanni Paoletti; Alessia Mariani; Luca Malvezzi; Francesca Pirola; Giuseppe Spriano; Giuseppe Mercante; Francesca Puggioni; Francesca Racca; Giulio Melone; Giacomo Malipiero; Sebastian Ferri; Giorgio Walter Canonica; Enrico Heffler
Journal:  Healthcare (Basel)       Date:  2022-01-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.